Status:

RECRUITING

Telerehabilitation Versus Centre-based Pulmonary Rehabilitaztion for Patients With Chronic Obstructive Pulmonary Disease

Lead Sponsor:

ADIR Association

Collaborating Sponsors:

Région Normandie

Département de la Seine Maritime

Conditions:

Chronic Obstructive Pulmonary Disease (COPD)

Eligibility:

All Genders

45-80 years

Phase:

NA

Brief Summary

Background and study aims: Chronic obstructive pulmonary disease is a leading cause of mortality worldwide. Pulmonary rehabilitation is recommended for patients to improve dyspnea, exercise capacity,...

Detailed Description

Chronic obstructive pulmonary disease is a disabling respiratory condition and a leading cause of mortality worldwide. Suggested treatments are mainly symptomatic and aim to stabilize the progression ...

Eligibility Criteria

Inclusion Criteria:

  • Age between 45 and 80 years
  • Confirmed diagnosis of chronic obstructive pulmonary disease, GOLD stage II to IV
  • Stable condition (no exacerbation in the last month prior to participation)
  • Referred to a pulmonary rehabilitation program
  • With or without oxygen during exercise
  • No pulmonary rehabilitation program in the last 12 months prior to participation
  • Living at home with another adult present during exercise sessions
  • Affiliated with a health insurance system
  • Able to read and understand the information letter and sign the consent form

Non-inclusion criteria:

  • Referred to pulmonary rehabilitation before lung cancer surgery
  • Referred to pulmonary rehabilitation before lung volume reduction surgery scheduled within the next four months
  • Visual, cognitive, or auditory impairments incompatible with participation in a tele-pulmonary rehabilitation program
  • Orthopedic, neurological, cardiovascular, or neuromuscular conditions limiting exercise training on a cycle ergometer
  • Active cancer
  • Unable to provide informed consent
  • Under legal guardianship or curatorship
  • Pregnant or breastfeeding women

Exclusion Criterion:

  • Withdrawal of consent

Key Trial Info

Start Date :

August 14 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2030

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT07025382

Start Date

August 14 2025

End Date

December 1 2030

Last Update

August 29 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Groupe Hospitalier du Havre

Montivilliers, France, 76290

2

Centre Hospitalier des Pays de Morlaix

Morlaix, France, 29600

3

Association ADIR

Rouen, France, 76000

4

Hôpital La Musse

Saint-Sébastien-de-Morsent, France, 27180